Skip to content

Advertisement

Open Peer Review Reports for: EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
7 Jan 2016 Submitted Original manuscript
29 Sep 2015 Reviewed Reviewer Report - Bernard Zonnenberg
23 Nov 2015 Reviewed Reviewer Report - Darcy Krueger
11 Mar 2016 Reviewed Reviewer Report - John Lawson
11 Apr 2016 Reviewed Reviewer Report - Deepti Dubey
2 Jun 2016 Author responded Author comments - Andras Fogarasi
Resubmission - Version 2
2 Jun 2016 Submitted Manuscript version 2
6 Jun 2016 Reviewed Reviewer Report - Deepti Dubey
19 Jul 2016 Author responded Author comments - Andras Fogarasi
Resubmission - Version 3
19 Jul 2016 Submitted Manuscript version 3
Publishing
2 Aug 2016 Editorially accepted
8 Aug 2016 Article published 10.1186/s12883-016-0658-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement